Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP452664.RAlzcrdlIB67SjKEGrwEzi3HEVsTIdupK4f99bGXvBEJA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP452664.RAlzcrdlIB67SjKEGrwEzi3HEVsTIdupK4f99bGXvBEJA130_assertion type Assertion NP452664.RAlzcrdlIB67SjKEGrwEzi3HEVsTIdupK4f99bGXvBEJA130_head.
- NP452664.RAlzcrdlIB67SjKEGrwEzi3HEVsTIdupK4f99bGXvBEJA130_assertion description "[Treatment of ovarian cancer HEY cells with 500 nM 5alpha-dihydrotestosterone (DHT), but not estradiol-17beta or progesterone, for 60 h down-regulated the expression of mRNA for TGF-beta receptors I and II (TbetaR-I and TbetaR-II), betaglycan, and endoglin but had no effect on TGF-beta1 mRNA levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452664.RAlzcrdlIB67SjKEGrwEzi3HEVsTIdupK4f99bGXvBEJA130_provenance.
- NP452664.RAlzcrdlIB67SjKEGrwEzi3HEVsTIdupK4f99bGXvBEJA130_assertion evidence source_evidence_literature NP452664.RAlzcrdlIB67SjKEGrwEzi3HEVsTIdupK4f99bGXvBEJA130_provenance.
- NP452664.RAlzcrdlIB67SjKEGrwEzi3HEVsTIdupK4f99bGXvBEJA130_assertion SIO_000772 10706107 NP452664.RAlzcrdlIB67SjKEGrwEzi3HEVsTIdupK4f99bGXvBEJA130_provenance.
- NP452664.RAlzcrdlIB67SjKEGrwEzi3HEVsTIdupK4f99bGXvBEJA130_assertion wasDerivedFrom befree-20140225 NP452664.RAlzcrdlIB67SjKEGrwEzi3HEVsTIdupK4f99bGXvBEJA130_provenance.
- NP452664.RAlzcrdlIB67SjKEGrwEzi3HEVsTIdupK4f99bGXvBEJA130_assertion wasGeneratedBy ECO_0000203 NP452664.RAlzcrdlIB67SjKEGrwEzi3HEVsTIdupK4f99bGXvBEJA130_provenance.